Loading
ニプロ(株) is a listed company. Its directors and officers file their transactions with EDINET (Japan FSA). 1 insider has disclosed 5 filings since 18 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
With 5 filings in twelve months, the company is more active than the median of 3 filings across the 3,429 companies we follow on the same exchange.
No insider has bought ニプロ(株) shares on the open market in the past twelve months. Filings reach the EDINET (Japan FSA) feed a median of 7 days after the trade. This delay matters because a trade only becomes useful information once it is public.
These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
· cache
8 of 8 declarations
Nipro Corporation is a Japanese company that specializes in the manufacturing of medical devices and pharmaceutical products. It is listed on the Tokyo Stock Exchange under the symbol XTKS.